Literature DB >> 7648459

Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase.

K Ito1, A Ishiguro, T Kanbe, K Tanaka, S Torii.   

Abstract

Candida albicans 46 kDa protein, a glycolytic enolase enzyme, is an important allergen of the yeast. The purpose of the study was to detect circulating IgE and IgG antibodies against C. albicans enolase (CAE). We isolated CAE using sequential DEAE Sephacel and P11 column chromatography from spheroplasts of C. albicans, and detected IgE and IgG antibody against CAE by immunoblotting. Crossreactivity of enolase of C. albicans and Saccharomyces cerevisiae was also examined by immunoblotting and immunoblot inhibition test. Among 54 sera with positive IgE RAST to C. albicans, IgE antibody against CAE was detected in 20 sera (37%) and IgG antibody in 27 sera (50%). The allergenic potency of CAE was confirmed using a skin-prick test in three patients. Simultaneous IgE binding to S. cerevisiae enolase was only observed in four out of 20 sera reacting to CAE. Pre-treatment of sera with CAE completely inhibited IgE binding to S. cerevisiae enolase. Whereas the latter only partially inhibited IgE binding to CAE. These results suggest that CAE shares some crossreacting epitopes with S. cerevisiae enolase, representing minor components of CAE but dominant segments of S. cerevisiae enolase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648459     DOI: 10.1111/j.1365-2222.1995.tb01089.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

Review 1.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

2.  Enzyme immunoassays for specific IgG and IgE antibodies to Pichia pastoris components in normal humans.

Authors:  W Ohtani; K Kobayashi; T Ohmura
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 3.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Evidence for the presence of immunoglobulin E antibodies specific to the cell wall phosphomannoproteins of Candida albicans in patients with allergies.

Authors:  T Kanbe; M Morishita; K Ito; K Tomita; K Utsunomiya; A Ishiguro
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate.

Authors:  Wenjia Gan; Guoxiong Zhao; Hongxu Xu; Weihua Wu; Wuying Du; Jiang Huang; Xinbing Yu; Xuchu Hu
Journal:  Parasitol Res       Date:  2010-02-02       Impact factor: 2.289

Review 6.  Mold allergens in respiratory allergy: from structure to therapy.

Authors:  Teresa E Twaroch; Mirela Curin; Rudolf Valenta; Ines Swoboda
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-11       Impact factor: 5.764

7.  Production of a Chaetomium globosum enolase monoclonal antibody.

Authors:  Brett J Green; Ajay P Nayak; Angela R Lemons; William R Rittenour; Justin M Hettick; Donald H Beezhold
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

Review 8.  Yeasts in the gut: from commensals to infectious agents.

Authors:  Jürgen Schulze; Ulrich Sonnenborn
Journal:  Dtsch Arztebl Int       Date:  2009-12-18       Impact factor: 5.594

9.  Extracellular enolase of Candida albicans is involved in colonization of mammalian intestinal epithelium.

Authors:  Richard C Silva; Ana Carolina B Padovan; Daniel C Pimenta; Renata C Ferreira; Claudio V da Silva; Marcelo R S Briones
Journal:  Front Cell Infect Microbiol       Date:  2014-06-03       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.